Michael Holgate is a Partner at Baird Capital, based in the United Kingdom. He has been with Baird Capital since June 2014.
Michael currently serves as a Board Member for Freemarket and JMAN Group, roles he has held since May 2023.
His previous experience includes board positions at Blue Matter and Vega Global, as well as roles in corporate finance at Spectrum Corporate Finance Limited and transaction services at PwC.
Earlier in his career, Michael worked as a research chemist at Synairgen Research Ltd and an analytical chemist at GSK.
Michael's extensive background in finance and chemistry provides a unique perspective in his current role at Baird Capital.